{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:44:33Z","timestamp":1776800673938,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.cyto.2016.12.014","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T07:32:54Z","timestamp":1483947174000},"page":"153-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo"],"prefix":"10.1016","volume":"91","author":[{"given":"Supriya","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Rani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niharika","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davinder","family":"Parsad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.12.014_b0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","article-title":"Quality of life in patients with vitiligo","volume":"1","author":"Parsad","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"issue":"5 Pt 1","key":"10.1016\/j.cyto.2016.12.014_b0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","article-title":"Vitiligo","volume":"38","author":"Kovacs","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.cyto.2016.12.014_b0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archderm.139.5.651","article-title":"Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease","volume":"139","author":"Plettenberg","year":"2003","journal-title":"Arch. Dermatol."},{"issue":"9","key":"10.1016\/j.cyto.2016.12.014_b0020","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.cyto.2016.12.014_b0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaad.2008.09.048","article-title":"The role of helper and regulatory T cells in the pathogenesis of vitiligo","volume":"60","author":"Basak","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.cyto.2016.12.014_b0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archderm.138.2.273","article-title":"Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines","volume":"138","author":"Moretti","year":"2002","journal-title":"Arch. Dermatol."},{"issue":"7","key":"10.1016\/j.cyto.2016.12.014_b0035","first-page":"849","article-title":"Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis","volume":"24","author":"Moretti","year":"2009","journal-title":"Histol. Histopathol."},{"issue":"6","key":"10.1016\/j.cyto.2016.12.014_b0040","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2008.08785.x","article-title":"Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera","volume":"159","author":"Ratsep","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"5 Pt 1","key":"10.1016\/j.cyto.2016.12.014_b0045","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","volume":"15","author":"Naughton","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2016.12.014_b0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5154.92668","article-title":"Serum concentration of IL-6, IL-2, TNF-alpha, and IFNgamma in Vitiligo patients","volume":"57","author":"Singh","year":"2012","journal-title":"Ind. J. Dermatol."},{"issue":"3","key":"10.1016\/j.cyto.2016.12.014_b0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res."},{"issue":"11","key":"10.1016\/j.cyto.2016.12.014_b0060","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrendo.2013.161","article-title":"Clinical implications of shared genetics and pathogenesis in autoimmune diseases","volume":"9","author":"Zhernakova","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.cyto.2016.12.014_b0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4(+)\/CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"issue":"9","key":"10.1016\/j.cyto.2016.12.014_b0070","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucl. Acids Res."},{"issue":"2","key":"10.1016\/j.cyto.2016.12.014_b0075","first-page":"160","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Taieb","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cyto.2016.12.014_b0080","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-4632.2009.03770.x","article-title":"Case detection rates of vitiligo by gender and age","volume":"48","author":"Kyriakis","year":"2009","journal-title":"Int. J. Dermatol."},{"issue":"3","key":"10.1016\/j.cyto.2016.12.014_b0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2016.12.014_b0090","series-title":"Vitiligo","first-page":"13","article-title":"Epidemiology, definitions and classification","author":"Taieb","year":"2010"},{"issue":"10","key":"10.1016\/j.cyto.2016.12.014_b0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2133.1956.tb12756.x","article-title":"The pathological varieties of vitiligo and their response to treatment with meladinine","volume":"68","author":"Jarrett","year":"1956","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.cyto.2016.12.014_b0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4103\/0019-5154.119949","article-title":"Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism","volume":"58","author":"Attili","year":"2013","journal-title":"Ind. J. Dermatol."},{"issue":"9","key":"10.1016\/j.cyto.2016.12.014_b0105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.cyto.2016.12.014_b0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0749.2003.00126.x","article-title":"Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders","volume":"17","author":"Imokawa","year":"2004","journal-title":"Pigment Cell Res."},{"issue":"1","key":"10.1016\/j.cyto.2016.12.014_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1755-148X.2011.00939.x","article-title":"Vitiligo as an inflammatory skin disorder: a therapeutic perspective","volume":"25","author":"Taieb","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"issue":"3","key":"10.1016\/j.cyto.2016.12.014_b0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.cyto.2016.12.014_b0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/pcmr.12355","article-title":"Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development","volume":"28","author":"Zhou","year":"2015","journal-title":"Pigment. Cell Melanoma Res."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616306056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616306056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T02:26:11Z","timestamp":1536114371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616306056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":25,"alternative-id":["S1043466616306056"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.12.014","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}